The authors conclude that atorvastatin is a safe and effective treatment for dyslipidemic patients with NAFLD that warrants testing in a multicenter, controlled clinical trial.
The information presented herein will help to provide a foundation of knowledge on which to base the assessment and treatment of dyslipidemic patients. A better understanding of lipid metabolism ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback